Pendium
RoadmapPricing
Get a demo
Dashboard
Dashboard
Loading…
/

Teach AI agents to recommend your brand to the right people.

Scan your visibilityBook a demo
Pendium
𝕏

Product

AI Visibility ScanYelp Listing AuditSite AuditContent for AI AgentsAgent Experience EngineAgent AnalyticsPricing

Industries

Local BusinessesRestaurantsHome ServicesBeauty & SpasHealth & MedicalFitness & GymsPet ServicesContractorsBars & NightlifeMoving CompaniesAuto DealershipsSaaS CompaniesSEO TeamsMarketing Teams

Tools

AI Visibility Site ScanYelp Listing AuditGBP AuditSocial Presence AuditBlog That Writes Itself

Real Life Examples

RipplingMasterclassThorneMonday.comPatagonia

Company

AboutResearchBook a DemoDocsPrivacy PolicyTerms of Service
© 2026 Manifest Labs. All rights reserved.
PrivacyTerms
Moderna, Inc.
Moderna, Inc.
Visibility94
Vibe83

This is a preview of our capabilities. To see the full results across all LLMs, run a full scan.

Businesses/Biotechnology / Biopharmaceuticals/Moderna, Inc.
Moderna, Inc.
AI Visibility & Sentiment

Moderna, Inc.

Moderna is a pioneering biotechnology company that leverages messenger RNA (mRNA) technology to develop a new class of transformative medicines. By treating medicine like software code, the company creates instructions for human cells to produce proteins that prevent, treat, or cure a wide range of diseases including infectious diseases, cancer, and rare ailments.

Active Monitoring
modernatx.com
Biotechnology / Biopharmaceuticals
Partial scan
AI Visibility Score
94/100

Excellent

Sentiment Score
83/100
Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core
94
OverviewLandscapeInsights & ActionsConversationsCitations

Is this your business?

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Moderna, Inc. today.

Moderna commands a dominant position in AI-driven search, consistently capturing top-tier visibility for its pioneering mRNA-based flu and oncology therapies. While the brand is a clear industry leader for specialized medical audiences, it faces a strategic blind spot in foundational corporate credibility queries where competitor narratives currently overshadow its footprint.

Working in your favor

Secures primary positioning for highly technical and clinical inquiries regarding individualized neoantigen therapies.

Maintains a perfect mention rate for key professional personas including Clinical Research Coordinators and Public Health Procurement Directors.

Leverages AI Overviews effectively to establish authority in mRNA vaccine comparisons against traditional technologies.

Gaps to close

Underperforms in brand-agnostic 'trust' and 'corporate credibility' searches where Moderna fails to appear as an industry benchmark.

Missing critical visibility in broad-market preventive care inquiries, specifically for RSV and COVID-19 booster decision-making.

Absence of brand reinforcement in general knowledge queries, signaling a weakness in top-of-funnel brand identity establishment.

Opportunities

Capitalize on the existing momentum in oncology to define the narrative around 'personalized cancer vaccines' before competitors consolidate the space.

Develop structured, authoritative content targeting the credibility gaps identified by procurement and trust-focused queries.

Strengthen the 'Preventive Care' content strategy to ensure Moderna remains the default answer for vaccine selection inquiries currently ceded to competitors.

Highest-Impact Actions
1

Develop and deploy an 'Industry Leadership and Credibility' content pillar focused on large-scale biotech manufacturing and quality assurance.

The current data shows a total absence in 'trusted biotech' and 'credibility evaluation' queries, allowing competitors to claim the narrative in high-stakes B2B search.

2

Optimize existing preventive care web assets to directly address specific RSV and COVID-19 booster selection criteria found in the AI Overview rankings.

Moderna is losing critical market share in consumer-facing vaccine queries where competitors like GSK and Pfizer are capturing the top search slots.

3

Launch a targeted digital campaign specifically curated for Clinical Research Coordinators to sustain and amplify the current top-positioning in therapeutic oncology.

While performance is strong here, maintaining this edge is vital to fending off encroaching competitors like BioNTech and those developing proprietary vaccines.

Value Proposition

Moderna’s proprietary mRNA platform functions as a standardized delivery system, allowing for the rapid design and scalable manufacturing of treatments for diseases previously considered undruggable.

Overview

Moderna is a pioneering biotechnology company that leverages messenger RNA (mRNA) technology to develop a new class of transformative medicines. By treating medicine like software code, the company creates instructions for human cells to produce proteins that prevent, treat, or cure a wide range of diseases including infectious diseases, cancer, and rare ailments.

Mission

To deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.

Products & Services
Spikevax (COVID-19 Vaccine)mRESVIA (RSV Vaccine)mRNA-4157 (Individualized Neoantigen Therapy)mRNA-1010 (Seasonal Influenza Vaccine Candidate)mRNA-1647 (Cytomegalovirus Vaccine Candidate)
Current State

Visibility Landscape

A high-level view of how Moderna, Inc. performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

ChatGPTChatGPT
ClaudeClaude
GeminiGemini
AI OverviewsAI Overviews

Reputation1q

Sentiment when asked about the brand directly

—
—
—
—
“What do you know about Moderna, Inc.? What do they do and what's their reputation?”
—
—
—
—

Core5q

Product/service category queries

—
—
—
94
“what are the best vaccine options for preventing rsv in older adults this year”
—
—
—
#3
“recommend some promising individualized neoantigen therapies for cancer patients”
—
—
—
#1
“what are the most trusted biotech companies for large scale vaccine manufacturing”
—
—
—
—
“compare the leading mrna based flu vaccine candidates to traditional ones”
—
—
—
#1
“what are the latest clinical advancements in cmv vaccines for preventing congenital issues”
—
—
—
—

Growth Areas3q

Adjacent, aspirational & visionary

—
—
—
—
“what should i look for in a covid-19 booster for the upcoming season”
—
—
—
—
“top companies developing personalized cancer vaccines right now”
—
—
—
—
“how do i evaluate the credibility of a biopharmaceutical manufacturer for new therapies”
—
—
—
—
ChatGPT
Claude
Gemini
AI Overviews

“What do you know about Moderna, Inc.? What do they do and what's their reputation?”

ChatGPT—
Claude—
Gemini—
AI Overviews—

“what are the best vaccine options for preventing rsv in older adults this year”

ChatGPT—
Claude—
Gemini—
AI Overviews#3

“recommend some promising individualized neoantigen therapies for cancer patients”

ChatGPT—
Claude—
Gemini—
AI Overviews#1

“what are the most trusted biotech companies for large scale vaccine manufacturing”

ChatGPT—
Claude—
Gemini—
AI Overviews—

“compare the leading mrna based flu vaccine candidates to traditional ones”

ChatGPT—
Claude—
Gemini—
AI Overviews#1

“what are the latest clinical advancements in cmv vaccines for preventing congenital issues”

ChatGPT—
Claude—
Gemini—
AI Overviews—

“what should i look for in a covid-19 booster for the upcoming season”

ChatGPT—
Claude—
Gemini—
AI Overviews—

“top companies developing personalized cancer vaccines right now”

ChatGPT—
Claude—
Gemini—
AI Overviews—

“how do i evaluate the credibility of a biopharmaceutical manufacturer for new therapies”

ChatGPT—
Claude—
Gemini—
AI Overviews—
Brand Ecosystem
1
Moderna, Inc.
6 mentions
2
GSK (Arexvy)
2 mentions
3
Pfizer (Abrysvo)
2 mentions
4
Merck
merck.com
2 mentions
5
Keytruda
2 mentions
6
Autogene Cevumeran
2 mentions
7
BioNTech
2 mentions
8
NeoVax
2 mentions
9
PGV001
2 mentions
10
Mount Sinai
mountsinai.org
2 mentions
11
Pfizer
2 mentions
Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Moderna, Inc.'s AI visibility.

Key Findings

Strength

Secures primary positioning for highly technical and clinical inquiries regarding individualized neoantigen therapies.

Strength

Maintains a perfect mention rate for key professional personas including Clinical Research Coordinators and Public Health Procurement Directors.

Strength

Leverages AI Overviews effectively to establish authority in mRNA vaccine comparisons against traditional technologies.

Recommended Actions

1

Develop and deploy an 'Industry Leadership and Credibility' content pillar focused on large-scale biotech manufacturing and quality assurance.

The current data shows a total absence in 'trusted biotech' and 'credibility evaluation' queries, allowing competitors to claim the narrative in high-stakes B2B search.

2

Optimize existing preventive care web assets to directly address specific RSV and COVID-19 booster selection criteria found in the AI Overview rankings.

Moderna is losing critical market share in consumer-facing vaccine queries where competitors like GSK and Pfizer are capturing the top search slots.

3

Launch a targeted digital campaign specifically curated for Clinical Research Coordinators to sustain and amplify the current top-positioning in therapeutic oncology.

While performance is strong here, maintaining this edge is vital to fending off encroaching competitors like BioNTech and those developing proprietary vaccines.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPTChatGPTClaudeClaudeGeminiGeminiAI OverviewsAI Overviews
Preventive Care And Vaccine Selection(3 queries)

“what are the best vaccine options for preventing rsv in older adults this year”

1/1 platforms mentioned

Core
AI OverviewsAI Overviews
1.GSK (Arexvy)
2.Pfizer (Abrysvo)
3.Moderna (mResvia)

“compare the leading mrna based flu vaccine candidates to traditional ones”

1/1 platforms mentioned

Core
Public Health Procurement Director · Procurement Lead
AI OverviewsAI Overviews
1.Pfizer
2.Moderna, Inc. (mRNA-1010, mRNA-1083)

“what should i look for in a covid-19 booster for the upcoming season”

0/0 platforms mentioned

Adjacent
Public Health Procurement Director · Procurement Lead
Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

RSV Vaccine Guidance for Adults - CDC

cdc.gov

Gov1 ref

Vaccines for Adults | RSV - CDC

cdc.gov

Gov1 ref

CDC Updates RSV Vaccination Recommendations for Adults

physiciansweekly.com

Web1 ref

RSV Recommendations and Guidance | Johns Hopkins

publichealth.jhu.edu

Edu1 ref

Should You Get an RSV Vaccine? | News - Yale Medicine

yalemedicine.org

Web1 ref

RSV Vaccination in Adults: What Healthcare Providers Need ...

lung.org

Web1 ref

What is the difference between Arexvy and Abrysvo?

drugs.com

Web1 ref

RSV Vaccine for Older Adults: What You Need to Know in 2025

ncoa.org

Web1 ref

09/15/25 Health Advisory: 2025–2026 respiratory-illness ...

providerresourceswa.org

Web1 ref

Flu & RSV Vaccine Guide Fall 2025 | Side Effects, Costs ...

healthexpressuc.com

Web1 ref

Advancements and challenges in personalized neoantigen-based ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Neoantigen cancer vaccines: a new star on the horizon - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at ...

mountsinai.org

Web1 ref

Neoantigen-based immunotherapy: advancing precision medicine in ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Exploring individualized neoantigen therapies in cancer | STAT

statnews.com

Web1 ref

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned March 16, 2026.

Explore Biotechnology / Biopharmaceuticals

View all
Biogen Inc.
Biogen Inc.
69/100

Start getting
recommended by AI.

Enter your website to see exactly what ChatGPT, Claude, and Gemini say about your business. Free, instant, and eye-opening.

Free visibility scanResults in 2 minutesNo credit card required

Frequently asked questions

Don't see your question? Book a demo and we'll walk you through it.

Moderna is a pioneering biotechnology company that leverages messenger RNA (mRNA) technology to develop a new class of transformative medicines. By treating medicine like software code, the company creates instructions for human cells to produce proteins that prevent, treat, or cure a wide range of diseases including infectious diseases, cancer, and rare ailments.

Moderna’s proprietary mRNA platform functions as a standardized delivery system, allowing for the rapid design and scalable manufacturing of treatments for diseases previously considered undruggable.

AI Visibility Score

Moderna, Inc. has an AI visibility score of 94/100, rated as excellent. This score reflects how often and how prominently Moderna, Inc. appears in responses from AI assistants like ChatGPT, Claude, and Gemini.

AI Perception Summary

Moderna commands a dominant position in AI-driven search, consistently capturing top-tier visibility for its pioneering mRNA-based flu and oncology therapies. While the brand is a clear industry leader for specialized medical audiences, it faces a strategic blind spot in foundational corporate credibility queries where competitor narratives currently overshadow its footprint.

Strengths

  • Secures primary positioning for highly technical and clinical inquiries regarding individualized neoantigen therapies.
  • Maintains a perfect mention rate for key professional personas including Clinical Research Coordinators and Public Health Procurement Directors.
  • Leverages AI Overviews effectively to establish authority in mRNA vaccine comparisons against traditional technologies.

Visibility Gaps

  • Underperforms in brand-agnostic 'trust' and 'corporate credibility' searches where Moderna fails to appear as an industry benchmark.
  • Missing critical visibility in broad-market preventive care inquiries, specifically for RSV and COVID-19 booster decision-making.
  • Absence of brand reinforcement in general knowledge queries, signaling a weakness in top-of-funnel brand identity establishment.

Competitors in AI Recommendations

  • GSK (Arexvy): 2 mentions
  • Pfizer (Abrysvo): 2 mentions
  • Merck: 2 mentions
  • Keytruda: 2 mentions
  • Autogene Cevumeran: 2 mentions
  • BioNTech: 2 mentions
  • NeoVax: 2 mentions
  • PGV001: 2 mentions
  • Mount Sinai: 2 mentions
  • Pfizer: 2 mentions
  • Roche: 1 mentions
  • Dana-Farber: 1 mentions
  • Broad Institute: 1 mentions
  • TG4050: 1 mentions
  • Transgene: 1 mentions

Categories: Biotechnology / Biopharmaceuticals